Dow Up0.11% Nasdaq Up0.50%

Cytokinetics, Incorporated (CYTK)

-NCM
4.28 Down 0.03(0.70%) Aug 29, 4:00PM EDT
|After Hours : 4.28 Up 0.00 (0.01%) Aug 29, 4:45PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 30,648   7,559   4,000  
Cost of Revenue -   -   -  
Gross Profit 30,648   7,559   4,000  
Operating Expenses
Research Development49,450  35,643  37,182  
Selling General and Administrative15,092  12,429  13,590  
Non Recurring -  (56)1,192  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (33,894) (40,457) (47,964)
Income from Continuing Operations
Total Other Income/Expenses Net177  87  104  
Earnings Before Interest And Taxes(33,717)(40,370)(47,860)
Interest Expense -   -   -  
Income Before Tax(33,717)(40,370)(47,860)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(33,717)(40,370)(47,860)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (33,717) (40,370) (47,860)
Preferred Stock And Other Adjustments -  (1,307)(2,857)
Net Income Applicable To Common Shares (33,717) (41,677) (50,717)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.